Hebei University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Baoding China (1921)

Organization Overview

First Clinical Trial
2005
NCT00125437
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Affiliated Hospital of Hebei University | Children's Hospital of Hebei Province | Department of Thoracic Surgery Fourth Hospital, Hebei Medical University, China | Fourth Hospital of Hebei Medical University, Tumor Hospital of Hebei Province | Hebei Fourth Hospital | Hebei General Hospital | Hebei Hospital of Traditional Chinese Medicine | Hebei Medical University | HeBei Medical University | Hebei Medical University Fourth Hospital | HeBei Medical University Fouth Hospital | Hebei Medical University Pharmaceutical Factory | Hebei Medical University Third Hospital | Hebei Petro China Center Hospital | Hebei Provincal Tumor Hospital | Hebei Provincial Cancer Hospital | Hebei Provincial Eye Hospital | Hebei Tumor Hospital | Hebei Yanda Hospital | Hebei Yanda Lu Daopei Hospital | HEBEI YANDA LUDAOPEI HOSPITAL | Hebei Yanda Lu Daopei Hospital, China | Hebei Yiling Hospital | Nanhe County Hospital of Hebei Province | People's Hospital of Hebei Province | The 4th Hospital of Hebei Medical University | The First Affiliated Hospital of Hebei North University | The First Hospital of Hebei Medical College | The First Hospital of Hebei Medical University | the First Hospital of Hebei Medical UniversityT | The Fourth Hospital of Hebei Medical University | The Fourth Hospital of Hebei Medical University (Hebei Tumor Hospital) | The People's Hospital of Hebei Province | the second hospital of Hebei medcial university | The Second Hospital of Hebei Medical University | Third Hospital of Hebei Medical University | Third Hospital of Hebei Medical University Department of Orthopaedic Surgery

Active Ingredients

Drugs in Phase 4 Trials (50)

allopurinol (zyloprim) (2 trials)

amphotericin b (fungizone) (1 trial)

Andrographis paniculata (1 trial)

azelastine (astelin) (1 trial)

azithromycin (zithromax) (1 trial)

bevacizumab (avastin) (5 trials)

budesonide (rhinocort) (1 trial)

butylphthalide (2 trials)

capecitabine (xeloda) (12 trials)

cephalexin (keflex) (1 trial)

ciprofloxacin (cipro) (1 trial)

cisatracurium (nimbex) (1 trial)

clavulanate (Augmentin) (1 trial)

cyclophosphamide (cytoxan) (17 trials)

dexmedetomidine (precedex) (3 trials)

doxorubicin (Doxil) (5 trials)

doxycycline (vibramycin) (1 trial)

durvalumab (imfinzi) (1 trial)

emtricitabine (emtriva) (5 trials)

endostatin (endostar) (2 trials)

fluticasone (cutivate) (1 trial)

insulin human (humulin) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

kallikrein (1 trial)

levothyroxine (Synthroid) (1 trial)

methotrexate (2 trials)

methylprednisolone (medrol) (1 trial)

minocycline (minocin) (1 trial)

naltrexone (revia) (1 trial)

oxaliplatin (eloxatin) (11 trials)

piperacillin (pipracil) (1 trial)

pirarubicin (1 trial)

prednisone (meticorten) (8 trials)

procaine benzylpenicillin (novocaine) (1 trial)

propofol (diprivan) (3 trials)

risedronate (actonel) (1 trial)

rocuronium (zemuron) (1 trial)

ropivacaine (naropin) (1 trial)

sevoflurane (ultane) (2 trials)

sodium aescinate (1 trial)

sodium chloride (3 trials)

somatropin (protropin) (3 trials)

tazobactam (Zosyn) (1 trial)

tenofovir (viread) (1 trial)

trastuzumab (herceptin) (3 trials)

triptorelin (Trelstar) (1 trial)

urea (3 trials)

vecuronium (norcuron) (1 trial)

wuling (1 trial)

xingnaojing (2 trials)

Drugs in Phase 3 Trials (46)

aminophylline (aminophyllin) (1 trial)

angongniuhuang (1 trial)

asparaginase (elspar) (1 trial)

bat5906 (1 trial)

borneol (1 trial)

bortezomib (velcade) (1 trial)

carboplatin (paraplatin) (4 trials)

cetuximab (erbitux) (2 trials)

cisplatin (platinol) (12 trials)

cytarabine (cytosar-u) (1 trial)

denosumab (prolia) (1 trial)

dexamethasone (2 trials)

docetaxel (taxotere) (11 trials)

Epimedium (2 trials)

epirubicin (ellence) (6 trials)

escitalopram (lexapro) (2 trials)

etoposide (vepesid) (3 trials)

Filgrastim (neupogen) (2 trials)

gimeracil (9 trials)

huachansu pian (1 trial)

huolingshengji (1 trial)

ifosfamide (ifex) (2 trials)

irinotecan (Camptosar) (2 trials)

lapatinib (tykerb) (15 trials)

lobaplatin (1 trial)

mercaptopurine (purinethol) (2 trials)

nedaplatin (2 trials)

nitric oxide (inomax) (1 trial)

oteracil (9 trials)

paclitaxel (taxol) (20 trials)

pembrolizumab (keytruda) (1 trial)

pomalidomide (pomalyst) (1 trial)

pyrotinib (2 trials)

ranibizumab (lucentis) (2 trials)

rc48-adc (1 trial)

riluzole (rilutek) (1 trial)

s-1 (7 trials)

sintilimab (2 trials)

sorafenib (nexavar) (1 trial)

tamoxifen (nolvadex) (1 trial)

tegafur (10 trials)

thalidomide (Thalomid) (1 trial)

thrombopoietin (1 trial)

toremifene (fareston) (1 trial)

vincristine (oncovin) (4 trials)

vinorelbine (navelbine) (3 trials)

Drugs in Phase 2 Trials (49)

adefovir dipivoxil (hepsera) (1 trial)

alprostadil (prostin) (1 trial)

atorvastatin (lipitor) (2 trials)

bat4406f (1 trial)

benfluorex (1 trial)

bone marrow derived mesenchymal stem cells (1 trial)

camrelizumab (4 trials)

cd19 car-t cells (6 trials)

cd7 car-t cell (2 trials)

chidamide (1 trial)

collagen (1 trial)

covid-19 mrna vaccine (2 trials)

cytokine induced killer cells (1 trial)

dalpiciclib (2 trials)

enoxaparin (lovenox) (1 trial)

ensartinib (2 trials)

entecavir (baraclude) (1 trial)

envafolimab (1 trial)

erlotinib (tarceva) (2 trials)

fcn-437c (1 trial)

fludarabine (fludara) (9 trials)

fluorouracil (efudex) (1 trial)

gemcitabine (gemzar) (1 trial)

gingiva mesenchymal stem cells (1 trial)

ginsenoside rg3 (1 trial)

glumetinib (1 trial)

goserelin (zoladex) (1 trial)

hs-10374 (1 trial)

hs-20089 (1 trial)

indocyanine green (ic-green) (2 trials)

kn060 (1 trial)

lamivudine (epivir) (1 trial)

letrozole (femara) (1 trial)

leucovorin (2 trials)

mrg002 (2 trials)

Nelonemdaz (1 trial)

nimotuzumab (2 trials)

olaparib (lynparza) (1 trial)

pegaspargase (oncaspar) (2 trials)

Raltitrexed (Tomudex) (1 trial)

sitagliptin (januvia) (1 trial)

stem cells (1 trial)

telbivudine (tyzeka) (1 trial)

temozolomide (temodar) (3 trials)

tenecteplase (tnkase) (1 trial)

tislelizumab (2 trials)

titanium (1 trial)

umbilical cord mesenchymal stem cells (4 trials)

zoledronic acid (zometa) (2 trials)

Drugs in Phase 1 Trials (17)

acetylsalicylic acid (aspirin) (1 trial)

allogeneic adipose derived mesenchymal stem cell (1 trial)

autologous apd-l1 armored anti-cd22 car t cells (1 trial)

autologous mesenchymal stem cells (3 trials)

bcma-pd1-cart cell (1 trial)

captopril (capoten) (1 trial)

carvedilol (coreg) (1 trial)

cd22 car-t cells (3 trials)

cd33 car-t cells (1 trial)

hsk16149 (1 trial)

metformin (glucophage) (1 trial)

mitoxantrone (novantrone) (1 trial)

peripheral blood mesenchymal stem cells (1 trial)

proxalutamide (1 trial)

spironolactone (aldactone) (2 trials)

syhx2011 (1 trial)

tangbi (1 trial)

Drugs in Other Trials (32)

anacaulase (NexoBrid) (1 trial)

astragalus membranaceus (1 trial)

auto car-t (4 trials)

autologous microbiome (1 trial)

avatrombopag (1 trial)

azacitidine (vidaza) (1 trial)

azimtamide (1 trial)

citalopram (celexa) (1 trial)

dendritic cells (1 trial)

fluoxetine (prozac) (1 trial)

fluvoxamine (luvox) (1 trial)

gabapentin (neurontin) (2 trials)

lomustine (1 trial)

methylene blue (proveblue) (1 trial)

omacetaxine (synribo) (1 trial)

paroxetine (paxil) (1 trial)

pilocarpine (ocusert) (1 trial)

pinellia (1 trial)

platelet-rich plasma (1 trial)

pregabalin (lyrica) (2 trials)

procarbazine (matulane) (1 trial)

proparacaine (ophthaine) (1 trial)

radix curcumae (1 trial)

radix scutellariae (1 trial)

rhizoma atractylodis (1 trial)

rhizoma coptidis (1 trial)

rhizoma zingiberis (1 trial)

roasted bighead atractylodes rhizome (1 trial)

sertraline (zoloft) (1 trial)

simethicone (IMODIUM) (1 trial)

spreading hedyotis herb (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 4)

Adenocarcinoma (Phase 4)

Adenocarcinoma of Lung (Phase 4)

Anemia (Phase 1)

Anemia, Aplastic (Phase 1)

Arm Injuries (Phase 4)

Arteriosclerosis (Phase 2)

Arteriosclerosis Obliterans (Phase 2)

Bone Neoplasms (Phase 3)

Brain Diseases (Phase 1)

Brain Edema (Phase 4)

Brain Ischemia (Phase 1)

Breast Neoplasms (Phase 4)

Bronchopulmonary Dysplasia (Phase 3)

Carcinoma (Phase 4)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 3)

Carcinoma, Squamous Cell (Phase 3)

Cardiomyopathies (Phase 1)

Cerebral Infarction (Phase 4)

Chronic Periodontitis (Phase 2)

Cognitive Dysfunction (Phase 4)

Colorectal Neoplasms (Phase 3)

Congenital Abnormalities (Phase 3)

Delayed Emergence from Anesthesia (Phase 4)

Delirium (Phase 4)

Dementia (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 3)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 2)

Dwarfism, Pituitary (Phase 4)

Endocrine System Diseases (Phase 4)

Esophageal Neoplasms (Phase 3)

Esophageal Squamous Cell Carcinoma (Phase 3)

Fallopian Tube Neoplasms (Phase 3)

Fibrosis (Phase 4)

Fracture Dislocation (Phase 2)

Giant Cell Tumor of Bone (Phase 3)

Giant Cell Tumors (Phase 3)

Glioma (Phase 2)

Headache (Phase 3)

Heart Failure (Phase 4)

Hemorrhage (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hypertension (Phase 1)

Hypertension, Pulmonary (Phase 1)

Hypertriglyceridemia (Phase 4)

Hyperuricemia (Phase 4)

Hypothyroidism (Phase 4)

Hypoxia (Phase 1)

Hypoxia-Ischemia, Brain (Phase 1)

Infarction (Phase 4)

Infertility (Phase 4)

Infertility, Female (Phase 4)

Ischemia (Phase 4)

Leukemia (Phase 3)

Leukemia, B-Cell (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 3)

Liver Cirrhosis (Phase 4)

Liver Neoplasms (Phase 4)

Lung Neoplasms (Phase 2)

Lupus Erythematosus, Systemic (Phase 1)

Lymphatic Metastasis (Phase 3)

Lymphoma (Phase 2)

Lymphoma, Extranodal NK-T-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Lymphoma, T-Cell (Phase 2)

Meningeal Carcinomatosis (Phase 4)

Meningitis (Phase 4)

Meningitis, Cryptococcal (Phase 4)

Multiple Myeloma (Phase 1)

Myocardial Infarction (Phase 2)

Neoplasm Metastasis (Phase 4)

Neoplasms (Phase 4)

Neoplasms, Experimental (Phase 2)

Neoplasms, Plasma Cell (Phase 1)

Neoplasms, Second Primary (Phase 4)

Ovarian Neoplasms (Phase 3)

Pancreatitis (Phase 4)

Parkinson Disease (Phase 4)

Periodontitis (Phase 2)

Peritoneal Neoplasms (Phase 3)

Pneumonia (Phase 4)

Polyneuropathies (Phase 1)

Post-Dural Puncture Headache (Phase 3)

Postoperative Complications (Phase 4)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Purpura, Thrombocytopenic, Idiopathic (Phase 3)

Recurrence (Phase 3)

Stomach Neoplasms (Phase 4)

Stroke (Phase 4)

Thrombocytopenia (Phase 3)

Triple Negative Breast Neoplasms (Phase 2)

Tuberculosis (Phase 4)

Tuberculosis, Meningeal (Phase 4)

Uterine Cervical Neoplasms (Phase 1)

Vascular Malformations (Phase 3)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 200
  • # of Trial APIs: 194